Noida based chemicals and drug maker Jubilant Organosys failed to witness good response to its buy back offer for all its outstanding foreign currency convertible bonds
(FCCBs) worth $241 million. The firm said, in a filing before Bombay Stock Exchange, that it would buy FCCBs worth $3 million due in 2010 with total cash of $2.55 million.
The firm received bids worth $48 million only for buy back shares via FCCB tender offer.